RenovoRx (RNXT) Prepaid Assets (2020 - 2026)
RenovoRx (RNXT) posted Prepaid Assets of $501000.0 for Q1 2026, up 130.88% sequentially from $217000.0 in Q4 2025, and up 5.03% YoY from $477000.0 in Q1 2025.
RenovoRx (RNXT) Prepaid Assets (2020 - 2026) Analysis & Trends
RenovoRx has reported Prepaid Assets for 7 years, with the latest figure at $501000.0 in Q1 2026.
- Quarterly Prepaid Assets rose 5.03% year-over-year to $501000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $501000.0 (up 5.03% YoY) and the FY2025 annual result came in at $217000.0, down 33.84% from the prior year.
- Prepaid Assets improved to $501000.0 in Q1 2026 per RNXT's latest filing, from $217000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.1 million in Q3 2022 and troughed at $24000.0 in Q4 2023.
- A 5-year average of $444235.3 and a median of $430000.0 in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets sank 97.09% in 2023, then soared 1266.67% in 2024.
- Over 5 years, Prepaid Assets stood at $825000.0 in 2022, then tumbled by 97.09% to $24000.0 in 2023, then jumped by 1266.67% to $328000.0 in 2024, then sank by 33.84% to $217000.0 in 2025, then surged by 130.88% to $501000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $501000.0, $217000.0, and $145000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | RenovoRx | 62.20 Mn | 62.20 Mn | 766,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 315,000.00 |
| Mar 31, 2026 | 501,000.00 |
| Dec 31, 2025 | 217,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Jun 30, 2025 | 430,000.00 |
| Mar 31, 2025 | 477,000.00 |
| Dec 31, 2024 | 328,000.00 |
| Sep 30, 2024 | 468,000.00 |
| Jun 30, 2024 | 262,000.00 |
| Mar 31, 2024 | 271,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Sep 30, 2023 | 252,000.00 |
| Jun 30, 2023 | 324,000.00 |
| Mar 31, 2023 | 592,000.00 |
| Dec 31, 2022 | 825,000.00 |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 478,000.00 |
| Mar 31, 2022 | 822,000.00 |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 439,000.00 |